Prices are updated after-hours

Nasdaq 12

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVJF | $12.37 -24.22% 380

(0.0% 1d) (0.0% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (83.09% volume)
Earnings Calendar:
Market Cap: $ 14,739,472,016
http://www.teva.co.il
Sec Filling | Patents | n/a employees

(IL) Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

cancer infectious disease pain relief israel cardiovascular

add to watch list Paper trade email alert is off

Checkpoint Therapeutics, Inc.

CKPT | $1.595 -4.49% -4.7% 470K

Health Technology

(0.0% 1d) (-10.1% 1m) (-42.7% 1y) (0.0% 2d) (0.0% 3d) (-2.3% 7d) (Infinity% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 55,803,115
http://www.checkpointtx.com
Sec Filling | Patents | 8 employees

(US) Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.

acquisitions cancer treatment

add to watch list Paper trade email alert is off

FuelCell Energy, Inc.

FCEL A | $0.9306 -6.94% -7.46% 69M

Electronic Technology

(0.0% 1d) (-19.1% 1m) (-55.1% 1y) (0.0% 2d) (0.0% 3d) (-8.8% 7d) (610.4% volume)
Earnings Calendar: 2023-12-19
Market Cap: $ 420,502,827
http://www.fuelcellenergy.com
Sec Filling | Patents | 538 employees

(US) FuelCell Energy, Inc. develops environmentally responsible distributed baseload power solutions through proprietary molten-carbonate fuel cell technology. It develops turn-key distributed power generation solutions and provides comprehensive services for the life of the power plant. The firm's fuel cell solution is an alternative to traditional combustion-based power generation and is complementary to an energy mix consisting of intermittent sources of energy, such as solar and wind turbines. It provides solutions for various applications, including utility-scale distributed generation, on-site power generation, combined heat and power, distributed hydrogen, carbon capture and hydrogen-based long duration storage. The Company's platform has the differentiating ability to do all these applications utilizing multiple sources of fuel including natural gas, renewable biogas, propane among others sources. The company was founded in 1969 and is headquartered in Danbury, CT.

hydrogen energy solar natural gas t-cell hepatitis renewable ceiling

add to watch list Paper trade email alert is off

Avid Bioservices, Inc.

CDMO M | $6.54 -2.53% -2.6% 710K

Health Technology

(0.0% 1d) (2.0% 1m) (-62.2% 1y) (0.0% 2d) (0.0% 3d) (6.6% 7d) (0.11% volume)
Earnings Calendar: 2023-12-05
Market Cap: $ 413,584,617
http://avidbio.com
Sec Filling | Patents | 222 employees

(United States) Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

t-cell avoid ceiling

add to watch list Paper trade email alert is off

Gilat Satellite Networks Ltd.

GILT | $5.36 2.29% 2.24% 160K

Electronic Technology

(0.0% 1d) (-5.6% 1m) (10.9% 1y) (0.0% 2d) (2.3% 3d) (-1.8% 7d) (-19.73% volume)
Earnings Calendar: 2023-08-08
Market Cap: $ 305,611,292
http://www.gilat.com
Sec Filling | Patents | 864 employees

Gilat Satellite Networks Ltd. engages in the provision of broadband satellite communication and networking solutions and services. It operates through the following business segments: Fixed Networks, Mobility Solutions, and Terrestrial Infrastructure Projects. The Fixed Networks segment provides advanced fixed broadband satellite communication networks, satellite communication systems and associated professional services and comprehensive turnkey solutions and fully managed satellite network services solutions. The Mobility Solutions segment provides advanced on-the-move satellite communications equipment, systems, and solutions, including airborne, maritime and ground-mobile satellite systems and solutions. The Terrestrial Infrastructure Projects segment provides network infrastructure construction of the fiber and microwave network of PRONATEL in Peru. The company was founded by Yoel Gat, Gideon Kaplan, Amiram Levinberg, Joshua Levinberg, and Shlomo Tirosh in 1987 and is headquartered in Petah Tikva, Israel.

israel satellite communication construction

add to watch list Paper trade email alert is off

Illumina, Inc.

ILMN | $116.64 -1.4% -1.41% 1.8M

Health Technology

(0.0% 1d) (-11.2% 1m) (-47.6% 1y) (0.0% 2d) (0.0% 3d) (-7.4% 7d) (9.9% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 18,575,548,106
http://www.illumina.com
Sec Filling | Patents | 7700 employees

(US) Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

genomic genetic

add to watch list Paper trade email alert is off

Nasdaq, Inc.

NDAQ | $60.075 0.11% 0.11% 2.3M

Finance

(0.0% 1d) (-1.4% 1m) (6.2% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (-0.26% volume)
Earnings Calendar: 2024-01-31
Market Cap: $ 34,555,534,693
http://www.nasdaq.com
Sec Filling | Patents | 4361 employees

(United States) Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information and public & private company services. It operates through the following segments: Market Services, Corporate Services, Information Services and Market Technology. The Market Services segment includes its equity derivative trading and clearing, cash equity trading, FICC and trade management services businesses. The Corporate Services segment includes its corporate solutions and listing services businesses. The Information Services segment includes data products, index licensing and services businesses. The Market Technology segment is a global technology solutions provider and partner to exchanges, clearing organizations, central securities depositories, regulators, banks, brokers and corporate businesses. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

security nash

add to watch list Paper trade email alert is off

Ocugen, Inc.

OCGN | News A | $1.315 -8.68% -9.51% 8M

Health Technology

(0.0% 1d) (6.5% 1m) (60.7% 1y) (0.0% 2d) (-15.4% 3d) (-17.0% 7d) (Infinity% volume)
Earnings Calendar: 2024-04-16
Market Cap: $ 338,382,722
http://www.ocugen.com
Sec Filling | Patents | 16 employees

(US) Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.

vaccine eye diseases eye

add to watch list Paper trade email alert is off

Processa Pharmaceuticals, Inc.

PCSA M | $1.56 -6.02% -6.41% 63K

Producer Manufacturing

(0.0% 1d) (-25.6% 1m) (-84.7% 1y) (0.0% 2d) (0.0% 3d) (9.6% 7d) (-24.73% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 4,455,330
http://www.processapharma.com
Sec Filling | Patents | 13 employees

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.

treatment

add to watch list Paper trade email alert is off

Hanmi Financial Corporation

HAFC A | $14.6 0.69% 0.68% 150K

Finance

(0.0% 1d) (-6.0% 1m) (-19.8% 1y) (0.0% 2d) (0.0% 3d) (-1.9% 7d) (44.47% volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 442,034,827
http://www.hanmi.com
Sec Filling | Patents | 633 employees

(US) Hanmi Financial Corp. is holding company, which engages in the provision of commercial banking and financial services. It offers checking, money market and savings, treasury management, and loans. The company was founded on March 14, 2000 and is headquartered in Los Angeles, CA.

add to watch list Paper trade email alert is off

Myriad Genetics, Inc.

MYGN F | $18.51 -0.7% -0.7% 640K

Health Technology

(0.0% 1d) (-16.2% 1m) (-14.8% 1y) (0.0% 2d) (0.0% 3d) (-2.8% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 1,663,584,140
http://www.myriad.com
Sec Filling | Patents | 2700 employees

(US) Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

molecular diagnostics genetic diagnostics information technology

add to watch list Paper trade email alert is off

ANI Pharmaceuticals, Inc.

ANIP | News S | $64.6 -1.34% -1.36% 180K

Health Technology

(0.0% 1d) (-3.5% 1m) (66.0% 1y) (0.0% 2d) (0.0% 3d) (-0.8% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 1,355,327,832
http://www.anipharmaceuticals.com
Sec Filling | Patents | 338 employees

(US) ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

hormone urea brands

Drugs

Aminocaproic Acid (Aminocaproic Acid)
ARIMIDEX (Anastrozole)
Aspirin and Extended-Release Dipyridamole (Aspirin and Extended-Release Dipyridamole)
ATACAND (Candesartan Cilexetil)
ATACAND HCT (Candesartan Cilexetil and Hydrochlorothiazide)
Bexarotene (Bexarotene)
Bicalutamide (Bicalutamide)
Bretylium Tosylate (bretylium tosylate)
Candesartan Cilexetil and Hydrochlorothiazide (Candesartan Cilexetil and Hydrochlorothiazide)
Carbidopa (Carbidopa)
CASODEX (Bicalutamide)
Cholestyramine (Cholestyramine)
Clobetasol Propionate (Emmolient) (Clobetasol Propionate)
Cortenema (Hydrocortisone)
CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE)
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate)
Diphenoxylate Hydrochloride and Atropine Sulfate (Diphenoxylate Hydrochloride and Atropine Sulfate)
Erythromycin Ethylsuccinate (Erythromycin Ethylsuccinate)
Esterified Estrogens and Methyltestosterone (Esterified Estrogens and Methyltestosterone)
Etodolac (Etodolac)
Ezetimibe and Simvastatin (Ezetimibe and Simvastatin)
Felbamate (Felbamate)
Fenofibrate (fenofibrate)
Fenofibrate (Fenofibrate)
Flecainide Acetate (Flecainide Acetate Tablet)
fluvoxamine maleate (Fluvoxamine maleate)
Hydrocortisone (Hydrocortisone)
Indapamide (Indapamide)
INDAPAMIDE (INDAPAMIDE)
INDERAL LA (propranolol hydrochloride)
Inderal XL (propranolol hydrochloride)
InnoPran XL (propranolol hydrochloride)
Isopropyl Alcohol Antiseptic 75% (Isopropyl Alcohol Antiseptic 75%)
Lithium Carbonate (Lithium Carbonate Extended-Release Tablet)
LITHOBID (lithium carbonate)
Memantine Hydrochloride (Memantine Hydrochloride)
Mesalamine (Mesalamine)
Methazolamide (Methazolamide)
Metoclopramide (Metoclopramide)
Mexiletine Hydrochloride (Mexiletine Hydrochloride)
MIGLUSTAT (MIGLUSTAT)
Morphine Sulfate (Morphine Sulfate)
Nilutamide (Nilutamide)
Nimodipine (Nimodipine)
Omega-3-Acid Ethyl Esters (Omega-3-Acid Ethyl Esters)
Opium Tincture Deodorized (morphine tincture)
Oxycodone Hydrochloride (Oxycodone Hydrochloride)
PALIPERIDONE (PALIPERIDONE)
Penicillamine (Penicillamine)
Pindolol (Pindolol)
Polyethylene Glycol 3350 (Polyethylene Glycol 3350)
Potassium Citrate (Potassium Citrate)
Prazosin Hydrochloride (Prazosin Hydrochloride)
Propafenone Hydrochloride (Propafenone Hydrochloride)
Propranolol Hydrochloride ER (propranolol hydrochloride)
Ranolazine (Ranolazine)
Reglan (Metoclopramide Hydrochloride)
Sulfamethoxazole and Trimethoprim (sulfamethoxazole and trimethoprim)
Temozolomide (Temozolomide)
Terbutaline Sulfate (Terbutaline Sulfate)
Vancocin (vancomycin hydrochloride)
vancomycin hydrochloride (vancomycin hydrochloride)
Vancomycin Hydrochloride (Vancomycin Hydrochloride)

add to watch list Paper trade email alert is off

Trimble Inc.

TRMB S | $57.84 -1.11% -1.12% 910K

Electronic Technology

(0.0% 1d) (-8.2% 1m) (23.9% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-12
Market Cap: $ 14,124,968,220
http://www.trimble.com
Sec Filling | Patents | 11484 employees

(US) Trimble, Inc. engages in the provision of positioning technology solutions. It operates through the following segments: Buildings and Infrastructure, Geospatial, Resources and Utilities, and Transportation. The Buildings and Infrastructure segment serves architects, engineers, contractors, owners, and operators. The Geospatial segment offers solutions for the customers working in surveying, engineering, and government. The Resources and Utilities segment caters customers working in agriculture, forestry, and utilities. The Transportation segment covers long-haul trucking, field service management, rail, and construction logistics industries. The company was founded in 1978 by Charles Robert Trimble and is headquartered in Sunnyvale, CA.

agricultural agriculture construction

add to watch list Paper trade email alert is off

Xos Inc

XOS A | $7.94 -3.52% -3.65% 23K

Manufacturing

(0.0% 1d) (-31.4% 1m) (1338.6% 1y) (0.0% 2d) (0.0% 3d) (-5.8% 7d) (11.18% volume)
Earnings Calendar: 2024-03-27
Market Cap: $ 61,537,049
https://xostrucks.com
Sec Filling | Patents | 1 employees

Xos, Inc. is an electric mobility company dedicated to making fleets more efficient. Xos designs and develops fully electric battery mobility systems specifically for commercial fleets. The company’s primary focus is on medium- and heavy-duty commercial vehicles that travel on "last mile" routes (i.e. predictable routes that are less than 200 miles per day). The company leverages its proprietary technologies to provide commercial fleets zero emission vehicles that are easier to maintain and more cost-efficient on a total cost of ownership (TCO) basis than their internal combustion engine and commercial EV counterparts.

batteries eletrical vehicles

add to watch list Paper trade email alert is off

Zoom Video Communications, Inc.

ZM S | $59.96 1.49% 1.47% 4.2M

Technology Services

(0.0% 1d) (-11.6% 1m) (-10.1% 1y) (0.0% 2d) (0.0% 3d) (-1.9% 7d) (-9.26% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 17,840,775,235
http://www.zoom.us
Sec Filling | Patents | 2532 employees

(US) Zoom Video Communications, Inc. engages in the provision of video-first communications platform. It connects people through frictionless video, voice, chat and content sharing, and enable face-to-face video experiences for thousands of people in a single meeting across disparate devices and locations. It focuses on customer and employee happiness, a video-first cloud architecture, recognized market leadership, viral demand, an efficient go-to-market strategy, and robust customer support. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

communication

add to watch list Paper trade email alert is off

Denso Corp

DNZOY | $18.56 0.08% 24K

Manufacturing

(0.0% 1d) (-4.2% 1m) (36.2% 1y) (0.0% 2d) (0.0% 3d) (-1.6% 7d) (19.94% volume)
Earnings Calendar:
Market Cap: $ 58,497,033,162
https://www.denso.com/jp/ja/
Sec Filling | Patents | n/a employees

(JP)

add to watch list Paper trade email alert is off

Astellas Pharma Inc

ALPMF | $9.594 43.47% 2.2K

Health Technology

(0.0% 1d) (-13.0% 1m) (-35.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (9745.45% volume)
Earnings Calendar:
Market Cap: $ 17,361,907,542
http://www.astellas.com
Sec Filling | Patents | n/a employees

(JP) Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

brands infectious disease metabolic diabetic diabetes

add to watch list Paper trade email alert is off

STMicroelectronics N.V.

STMEF | $40.39 -5.77% 2.8K

Electronic Technology

(0.0% 1d) (-8.4% 1m) (-14.0% 1y) (0.0% 2d) (0.0% 3d) (-0.5% 7d) (-98.16% volume)
Earnings Calendar:
Market Cap: $ 36,722,876,950
http://www.st.com
Sec Filling | Patents | n/a employees

(CH) STMicroelectronics NV designs, develops, manufactures and markets products, which offers discrete and standard commodity components, application-specific integrated circuits, full custom devices and semi-custom devices for analog, digital and mixed-signal applications. It operates through the following segments: Automotive and Discrete Group, Analog and MEMS Group, and Microcontrollers and Digital ICs Group. The Automotive and Discrete Group segment comprises of all dedicated automotive ICs, and discrete and power transistor products. The Analog and MEMS Group segment comprises of low-power high-end analog ICs, smart power products for industrial, computer and consumer markets, touch screen controllers, low power connectivity solutions and metering solutions for smart grid and all MEMS products. The Microcontrollers and Digital ICs Group segment comprises of general purpose and secure microcontrollers, EEPROM memories, and digital ASICs. The company was founded in June 1987 and is headquartered in Plan-Les-Ouates, Switzerland.

automotive computational security

add to watch list Paper trade email alert is off

Denso Corp

DNZOF | $18.74 258.83% 2.3K

Producer Manufacturing

(0.0% 1d) (1.5% 1m) (-65.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-53.68% volume)
Earnings Calendar:
Market Cap: $ 59,064,353,527
http://www.denso.com/jp/ja/
Sec Filling | Patents | n/a employees

(JP) DENSO Corp. engages in the manufacture and sale of automotive component and systems, industrial products, and home appliances. It operates through the following business divisions: Automotive, Consumer Products, Industrial Products, and New Business Fields. The Automotive division develops and manufactures powertrain control systems, gasoline and diesel engine management systems, semiconductor sensors, micro electronic devices, car and bus air conditioning systems, telematic products, body electronics, windshield wiper systems, power windows, power steering, and power sliding doors. The Consumer Products division offers CO2 refrigerant heat-pump water heaters, central air conditioners, and home energy management systems (HEMS). The Industrial Products division provides factory automation products such as industrial robots and programmable logic controllers. It also handles automatic identification products such as bar-code readers, quick response (QR) code readers, and integrated circuit (IC) card-related products. The New Business Fields division deals with energy management, agriculture technology, security, community network solution, healthcare, biotechnology, and electric power assistance technology. The company was founded on December 16, 1949 and is headquartered in Kariya, Japan.

hepatitis semiconductor agricultural energy automotive electronics agriculture security eletrical sensor

add to watch list Paper trade email alert is off

XOMA Corporation

XOMA | News | $24.96 2.93% 2.84% 15K

Health Technology

(0.0% 1d) (-1.5% 1m) (29.6% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (-100.0% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 290,409,974
http://www.xoma.com
Sec Filling | Patents | 10 employees

(US) XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

antibody

add to watch list Paper trade email alert is off